Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Heart Failure Drugs: β-Blockers01:22

Heart Failure Drugs: β-Blockers

1.1K
β-adrenergic antagonists, commonly known as β-blockers, block the effects of sympathetic neurotransmitters such as noradrenaline (NA) and adrenaline (ADR). They have several beneficial effects in heart failure treatment. They reduce heart rate, the force of contraction, and cardiac muscle relaxation. They also slow the atrial-ventricular conduction rate and raise the threshold for arrhythmias. The concentration of β-blockers determines their effects on bronchodilation,...
1.1K
Adrenergic Antagonists: Pharmacological Actions of β-Receptor Blockers01:27

Adrenergic Antagonists: Pharmacological Actions of β-Receptor Blockers

1.9K
β-receptor blockers significantly impact the cardiovascular system by counteracting catecholamine-induced sympathetic responses. These medications decrease heart rate, contractility, and cardiac output, potentially leading to cardiac depression, life-threatening bradycardia, and death. Therapeutically, β-blockers function as mild antihypertensives and are utilized in treating angina pectoris and cardiac arrhythmias. However, nonselective β-blockers inhibit β2-receptors in...
1.9K
Adrenergic Antagonists: ɑ and β-Receptor Blockers01:31

Adrenergic Antagonists: ɑ and β-Receptor Blockers

1.4K
Third-generation β-blockers, such as labetalol and carvedilol, represent a significant advancement in managing cardiovascular conditions. Unlike conventional β-blockers, which can induce peripheral vasoconstriction, third-generation drugs block α1 adrenoceptors. This promotes vasodilation through several mechanisms, such as increased nitric oxide production, inhibition of calcium ion entry, opening of potassium ion channels, and antioxidant action. Labetalol, for instance, is...
1.4K
Exercise and Cardiovascular Response01:20

Exercise and Cardiovascular Response

4.9K
Exercise significantly impacts cardiovascular response, which is crucial for understanding patient health and designing effective treatment plans.
Light to moderate physical activity initiates a series of interconnected responses in the body. The heart rate modestly increases in anticipation of the workout, followed by widespread vasodilation as oxygen consumption by skeletal muscles increases. This results in decreased peripheral resistance, increased capillary blood flow, and accelerated...
4.9K
Antihypertensive Drugs: Types of β-Blockers01:28

Antihypertensive Drugs: Types of β-Blockers

1.9K
β receptors are classified into three subclasses: β1, β2, and β3. β1 receptors are primarily located in the heart and kidneys. When they get activated, they increase heart rate, contractility, and renin release. This process enhances blood pressure and aids in stress management. In contrast, β2 receptors are situated mainly in the lungs, blood vessels, and skeletal muscles. Upon activation, they trigger smooth muscle relaxation, causing bronchodilation and...
1.9K
Adrenergic Antagonists: Chemistry and Classification of β-Receptor Blockers01:25

Adrenergic Antagonists: Chemistry and Classification of β-Receptor Blockers

1.6K
β-adrenergic antagonists, or β-blockers, modulate the sympathetic nervous system by targeting β-adrenoceptors and inhibiting catecholamine-mediated sympathetic responses. β-blockers differ in their adrenoceptor subtype affinity, lipophilicity, and α-blocking capabilities. The history of β-blocker development began with the prototype, dichloroisoprenaline, which exhibited partial agonist activity. As a result, propranolol was developed as a pure antagonist but...
1.6K

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Physical Activity and the Asthmatic.

The Physician and sportsmedicine·2016
Same author

The Diphtheria Epidemic in Halifax.

Canadian Medical Association journal·2010
Same author

Rationale for continuous chest compression cardiopulmonary resuscitation.

Heart (British Cardiac Society)·2009
Same author

Monitoring 6 weeks of progressive endurance training with plasma glutamine.

International journal of sports medicine·2006
Same author

Modality choice among Aboriginal incident dialysis patients--influence of geographic location.

Peritoneal dialysis international : journal of the International Society for Peritoneal Dialysis·2006
Same author

Neuroendocrine properties of intrinsic cardiac adrenergic cells in fetal rat heart.

American journal of physiology. Heart and circulatory physiology·2004
Same journal

Injury surveillance during the 2024 under 20s Men's European Field Lacrosse Championships.

The Physician and sportsmedicine·2026
Same journal

Understanding health insurance and the delay in care for partial meniscectomies: a comparison between public and private coverage.

The Physician and sportsmedicine·2026
Same journal

Injury incidence and risk factors in youth American football versus soccer: a national emergency department analysis.

The Physician and sportsmedicine·2026
Same journal

Links between concussion history, hypertension, and hypertension contributing factors among adolescent football athletes.

The Physician and sportsmedicine·2026
Same journal

Core muscle endurance and balance as predictors of lateral ankle sprain in adolescent team-sport athletes: a prospective cohort study.

The Physician and sportsmedicine·2026
Same journal

Impact of Achilles tendon rupture on performance and career outcomes in NFL players: a matched cohort study.

The Physician and sportsmedicine·2026
See all related articles

Related Experiment Video

Updated: Mar 18, 2026

Surgical Placement of Catheters for Long-term Cardiovascular Exercise Testing in Swine
12:37

Surgical Placement of Catheters for Long-term Cardiovascular Exercise Testing in Swine

Published on: February 9, 2016

14.0K

Beta-Blockade and Response to Exercise: Influence of Training.

J H Wilmore, M J Joyner, B J Freund

    The Physician and Sportsmedicine
    |July 14, 2016
    PubMed
    Summary
    This summary is machine-generated.

    Beta-blockers and exercise training impact exercise capacity differently. Beta-blockade may increase capacity in angina patients but decrease it in highly fit individuals.

    More Related Videos

    Conducting Maximal and Submaximal Endurance Exercise Testing to Measure Physiological and Biological Responses to Acute Exercise in Humans
    07:26

    Conducting Maximal and Submaximal Endurance Exercise Testing to Measure Physiological and Biological Responses to Acute Exercise in Humans

    Published on: October 17, 2018

    21.5K
    Cardiac Response to β-Adrenergic Stimulation Determined by Pressure-Volume Loop Analysis
    08:05

    Cardiac Response to β-Adrenergic Stimulation Determined by Pressure-Volume Loop Analysis

    Published on: May 19, 2021

    4.2K

    Related Experiment Videos

    Last Updated: Mar 18, 2026

    Surgical Placement of Catheters for Long-term Cardiovascular Exercise Testing in Swine
    12:37

    Surgical Placement of Catheters for Long-term Cardiovascular Exercise Testing in Swine

    Published on: February 9, 2016

    14.0K
    Conducting Maximal and Submaximal Endurance Exercise Testing to Measure Physiological and Biological Responses to Acute Exercise in Humans
    07:26

    Conducting Maximal and Submaximal Endurance Exercise Testing to Measure Physiological and Biological Responses to Acute Exercise in Humans

    Published on: October 17, 2018

    21.5K
    Cardiac Response to β-Adrenergic Stimulation Determined by Pressure-Volume Loop Analysis
    08:05

    Cardiac Response to β-Adrenergic Stimulation Determined by Pressure-Volume Loop Analysis

    Published on: May 19, 2021

    4.2K

    Area of Science:

    • Cardiology
    • Exercise Physiology

    Background:

    • Cardiovascular disease and hypertension management often involves beta-blockers and exercise training.
    • The interaction between these two common treatment modalities requires further investigation.

    Purpose of the Study:

    • To investigate the combined effects of beta-blockers and exercise training on exercise capacity.
    • To determine how beta-blockade influences exercise capacity across different fitness levels.

    Main Methods:

    • Analysis of data from four studies.
    • Inclusion of 93 subjects over a five-year period.
    • Assessment of exercise capacity under beta-blockade in various populations.

    Main Results:

    • Beta-blockade increased exercise capacity in angina patients.
    • Beta-blockade decreased exercise capacity in highly trained individuals.
    • Beta-blockade had minimal to no effect on healthy, untrained individuals.

    Conclusions:

    • Beta-blockade exhibits a differential effect on exercise capacity based on an individual's health and fitness status.
    • The findings highlight the importance of personalized treatment strategies when combining beta-blockers and exercise.
    • Further research may elucidate the precise mechanisms behind these varied responses.